Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
20%
OVERLAP
BY WEIGHT
16
# OF OVERLAPPING
HOLDINGS
XPH
59
HOLDINGS
27%
ALSO IN SBIO
SBIO
86
HOLDINGS
19%
ALSO IN XPH
SECTOR DRIFT (XPH minus SBIO)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XPH |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
CRINETICS PHARMACEUTICALS INC | 3.5% | 4.4% | 3.5% |
|
DEFINIUM THERAPEUTICS INC | 2.7% | 2.4% | 2.4% |
|
AMYLYX PHARMACEUTICALS, INC. | 4.1% | 2.1% | 2.1% |
|
EDGEWISE THERAPEUTICS, INC. | 1.9% | 2.4% | 1.9% |
|
MBX BIOSCIENCES INC | 3.0% | 1.6% | 1.6% |
XPH Overweight Relative to SBIO
|
OMEROS CORP | 2.7% |
|
ENLIVEN THERAPEUTICS, INC. | 2.3% |
|
CORCEPT THERAPEUTICS INC | 2.2% |
|
ETON PHARMACEUTICALS, INC. | 2.1% |
|
AMYLYX PHARMACEUTICALS, INC. | 1.9% |
|
TREVI THERAPEUTICS, INC. | 1.9% |
|
MERCK & CO. INC. | 1.8% |
 |
PERRIGO CO | 1.8% |
|
OCULAR THERAPEUTIX INC | 1.8% |
|
BRISTOL-MYERS SQUIBB CO | 1.7% |
XPH Underweight Relative to SBIO
|
APOGEE THERAPEUTICS, INC. | -4.1% |
|
CG ONCOLOGY, INC. | -3.5% |
|
ORUKA THERAPEUTICS INC | -3.2% |
|
TRAVERE THERAPEUTICS, INC. | -3.0% |
|
DIANTHUS THERAPEUTICS INC | -3.0% |
|
ACADIA PHARMACEUTICALS INC | -2.5% |
|
DYNE THERAPEUTICS INC | -2.1% |
|
RELAY THERAPEUTICS, INC. | -2.1% |
|
DENALI THERAPEUTICS INC. | -2.0% |
|
IDEAYA BIOSCIENCES, INC. | -1.7% |